Market Place
Sourcing Support
Biocodex Announces DIACOMIT® Oral Suspension for Dravet Syndrome
14 Nov 2024 //
PR NEWSWIRE
Antiseizure Drug DIACOMIT Now Approved for Children as Young as 6 Months
21 Sep 2022 //
PRNEWSWIRE
PANTHERx Rare Announces Partnership with Biocodex for Distribution of DIACOMIT
27 Jun 2022 //
PRNEWSWIRE
M8 Pharmaceuticals Bags License of Exclusive rights for Diacomit from Biocodex
14 Sep 2021 //
PRNEWSWIRE
Zogenix Ready to Resubmit Fintepla for Rare Epilepsy to FDA
27 Jun 2019 //
BIOSPACE
Encoded Therapeutics bags $104M to propel `precision gene therapy’
26 Jun 2019 //
FIERCE BIOTECH
2018 Drug Approvals: A Closer Look
05 Feb 2019 //
SCIENCE MAG BLOG
FDA approves DIACOMIT (Stiripentol) for seizures
24 Aug 2018 //
PR NEWSWIRE
SMC accepts 4 new medicines
12 Sep 2017 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.